DEFIBRILLATOR WILL BE SOLD EXCLUSIVELY BY GE HEALTHCARE WORLDWIDE

Cardiac Science Corporation, a global leader in advanced cardiac monitoring and defibrillation products, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) regulatory clearance to market a new 'crash cart' defibrillator-monitor designed specifically for use by medical professionals to respond to cardiac emergencies in hospital settings. The new defibrillator will be sold exclusively by GE Healthcare (GE), a division of General Electric Company in accordance with previously concluded agreements.
NewsCom